Provided by Tiger Trade Technology Pte. Ltd.

Ecopetrol SA

17.30
-0.2300-1.31%
Volume:772.78K
Turnover:13.30M
Market Cap:35.57B
PE:9.09
High:17.33
Open:17.23
Low:17.06
Close:17.53
52wk High:18.19
52wk Low:8.57
Shares:2.06B
Float Shares:237.00M
Volume Ratio:0.65
T/O Rate:0.33%
Dividend:0.99
Dividend Rate:5.73%
EPS(TTM):1.90
EPS(LYR):1.16
ROE:15.95%
ROA:7.31%
PB:1.74
PE(LYR):14.85

Loading ...

Press Release: Santhera Pharmaceuticals Full Year Results for the Year Ended 31 December 2025

Dow Jones
·
Apr 28

Crinetics Pharmaceuticals Announces the European Commission Approval of PALSONIFY® (Paltusotine) for the Treatment of Acromegaly in Adults

GlobeNewswire
·
Apr 28

Novartis announces EC approved Rhapsido for CSU

TIPRANKS
·
Apr 27

EC World REIT Slides Deeper Into Distress as Earnings, Valuations and Distributions Collapse

TIPRANKS
·
Apr 27

Novartis Rhapsido® receives European Commission approval as first oral targeted treatment for chronic spontaneous urticaria

GlobeNewswire
·
Apr 27

Rivelle Tampines EC 100% sold in second round of balloting

Gerine Tang Yi Qian
·
Apr 26

Novartis receives positive CHMP opinion for Itvisma® for spinal muscular atrophy (SMA)

GlobeNewswire
·
Apr 24

EUA prices: The key variable in Europe’s green steel transition

Fastmarkets
·
Apr 24

Press Release: Ecopetrol enters into an Agreement to acquire an equity stake in Brava Energia S.A. a company domiciled in Brazil

Dow Jones
·
Apr 24

Press Release: Ipsen delivers strong sales in the first quarter of 2026 and confirms its full-year guidance

Dow Jones
·
Apr 23

Moderna receives EC marketing authorization for mCOMBRIAX

TIPRANKS
·
Apr 21

EC Healthcare to Acquire Remaining 10% Stake in Target Company via Put Option

TIPRANKS
·
Apr 21

Lundbeck presents new data at AAN 2026 highlighting real-world changes in migraine-related cognitive symptoms after starting VYEPTI® (eptinezumab)

prnewswire
·
Apr 20

Ecopetrol Anticipates Copoazú-1 Well Test Results by End of June

Deep News
·
Apr 18

Dupixent® (dupilumab) Approved in the EU as the First Targeted Medicine to Treat Young Children with Chronic Spontaneous Urticaria (CSU)

GlobeNewswire
·
Apr 13

Rhythm Pharmaceuticals to Report First Quarter 2026 Financial Results on Tuesday, May 5, 2026

GlobeNewswire
·
Apr 09

Ecopetrol Board Approves President's Unpaid Leave of Absence

MT Newswires Live
·
Apr 07

Market Chatter: Ecopetrol Grants CEO Ricardo Roa Extended Holiday, Unpaid Leave of Absence

MT Newswires Live
·
Apr 07

Ecopetrol Receives Approval for $1.25 Billion Loan to Refinance Debt

MT Newswires Live
·
Apr 06

Rhythm Pharmaceuticals Announces Changes to Board of Directors

GlobeNewswire
·
Apr 03